ALK buys shares in a new biotech firm with an experienced leader

20 April 2020

A one-year-old biotech firm can now count one of Denmark’s largest pharmaceutical companies among its owners. ALK hopes the company is sitting on effective allergy treatment.


Key publication for company technology: Computational Evolution of Threonine-Rich β-Hairpin Peptides Mimicking Specificity and Affinity of Antibodies

27 February 2020

The development of recognition molecules with antibody-like properties is of great value to the biotechnological and bioanalytical communities. The recognition molecules presented here are peptides with a strong tendency to form β-hairpin structures, stabilized by alternate threonines, which are located at one face of the peptide.